7Baggers

Biomea Fusion, Inc.
(NASDAQ:BMEA) 

BMEA stock logo

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibit...

Founded: 2017
CEO: Thomas Butler  
Sector: Healthcare
Industry: Biotechnology
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                        
      operating expenses:
    		                    
      research and development
    		8,115,000 14,401,000 16,566,000 22,897,000 25,240,000 27,244,000 31,825,000 33,776,000 30,866,000 25,347,000 21,938,000 24,395,000 20,539,000 18,242,000 12,582,000 11,350,000 11,088,000 7,886,000 5,224,000 3,798,000 
      general and administrative
    		3,604,000 4,199,000 4,710,000 6,815,000 4,834,000 6,795,000 7,073,000 7,283,000 6,462,000 5,772,000 5,719,000 5,636,000 5,737,000 5,242,000 4,892,000 5,050,000 3,649,000 4,752,000 3,211,000 2,059,000 
      impairment of long-lived assets
    		 2,205,000                   
      total operating expenses
    		11,719,000 20,805,000 21,276,000 29,712,000 30,074,000 34,039,000 38,898,000 41,059,000 37,328,000 31,119,000 27,657,000 30,031,000 26,276,000 23,484,000 17,474,000 16,400,000 14,737,000 12,638,000 8,435,000 5,857,000 
      income from operations
    		-11,719,000 -20,805,000 -21,276,000 -29,712,000 -30,074,000 -34,039,000 -38,898,000 -41,059,000 -37,328,000 -31,119,000 -27,657,000 -30,031,000 -26,276,000 -23,484,000 -17,474,000 -16,400,000 -14,737,000 -12,638,000 -8,435,000 -5,857,000 
      yoy
    		-61.03% -38.88% -45.30% -27.64% -19.43% 9.38% 40.64% 36.72% 42.06% 32.51% 58.28% 83.12% 78.30% 85.82% 107.16% 180.01%     
      qoq
    		-43.67% -2.21% -28.39% -1.20% -11.65% -12.49% -5.26% 10.00% 19.95% 12.52% -7.91% 14.29% 11.89% 34.39% 6.55% 11.28% 16.61% 49.83% 44.02%  
      interest and other income
    		1,346,000 4,398,000 536,000 450,000 772,000 1,252,000 1,622,000 1,998,000 2,444,000 2,690,000 2,766,000 980,000 962,000 594,000 216,000 34,000 27,000 32,000 36,000 5,000 
      net and comprehensive loss
    		-16,602,250 -16,407,000 -20,740,000 -29,262,000                 
      net loss per common share, basic and diluted
    		270 -270 -510 -800 -800 -910 -1,030 -1,090 -615 -800 -700 -980 -482.5 -780 -590 -560 -302.5 -430 -330 -490 
      weighted-average number of common shares used to compute basic and diluted net loss per common share
    		52,228,068,000 59,848,325,000 40,630,403,000 36,627,148,000 36,105,671,000 36,220,736,000 36,043,561,000 35,890,370,000 34,106,923 35,653,988,000 35,348,293,000 29,586,468,000 29,271,777 29,319,042,000 29,196,398,000 29,126,088,000  29,001,213,000 25,161,038,000 11,964,205,000 
      net income
    		    -29,302,000 -32,787,000 -37,276,000 -39,061,000 -34,884,000 -28,429,000 -24,891,000 -29,051,000 -25,314,000 -22,890,000 -17,258,000 -16,366,000 -14,710,000 -12,606,000 -8,399,000 -5,852,000 
      yoy
    		    -16.00% 15.33% 49.76% 34.46% 37.81% 24.20% 44.23% 77.51% 72.09% 81.58% 105.48% 179.67%     
      qoq
    		    -10.63% -12.04% -4.57% 11.97% 22.71% 14.21% -14.32% 14.76% 10.59% 32.63% 5.45% 11.26% 16.69% 50.09% 43.52%  
      other comprehensive loss:
    		                    
      unrealized gain on investments
    		           1,000 12,000 4,000 6,000 -13,000 -12,000    
      comprehensive loss
    		    -29,302,000 -32,787,000 -37,276,000 -39,061,000 -34,883,000 -28,429,000 -24,891,000 -29,050,000 -25,302,000 -22,886,000 -17,252,000 -16,379,000 -14,722,000 -12,606,000 -8,382,000 -5,867,000 
      changes in unrealized gain on short term investments
    		                  17,000  
      changes in unrealized loss on short term investments
    		                   -15,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                           
        assets
      		                     
        current assets:
      		                     
        cash and cash equivalents
      		44,693,000 55,812,000 46,642,000 56,224,000 35,864,000 58,279,000 87,952,000 113,286,000 144,918,000 176,866,000 199,090,000 222,908,000 86,300,000 111,899,000 132,311,000 148,481,000 156,215,000 145,736,000 156,974,000 166,037,000 18,891,000 
        prepaid expenses and other current assets
      		1,256,000 2,238,000 2,798,000 8,439,000 8,821,000 10,053,000 5,646,000 3,002,000 2,648,000 2,315,000 3,414,000 3,028,000 2,631,000 4,770,000 5,403,000 4,505,000 2,217,000 3,045,000 1,698,000 1,949,000 2,045,000 
        restricted cash, current
      		369,000                     
        total current assets
      		46,318,000 58,050,000 49,440,000 64,663,000 44,685,000 68,332,000 93,598,000 116,288,000 147,566,000 179,181,000 202,504,000 225,936,000 88,931,000 117,819,000 138,861,000 154,138,000 167,023,000 176,561,000 191,103,000 200,521,000 47,522,000 
        property and equipment
      		67,000 153,000 200,000 2,831,000 3,298,000 3,766,000 4,228,000 4,445,000 4,806,000 5,159,000 5,575,000 5,979,000 6,292,000 5,841,000 3,049,000 2,997,000 2,894,000 2,965,000 2,963,000 1,495,000 165,000 
        restricted cash, non-current
      		                     
        total assets
      		46,385,000 58,572,000 55,187,000 73,163,000 55,055,000 79,938,000 110,419,000 136,164,000 168,494,000 199,927,000 225,087,000 248,674,000 112,638,000 129,307,000 145,050,000 161,736,000 174,864,000 185,705,000 199,403,000 209,533,000 59,875,000 
        liabilities and stockholders' equity
      		                     
        current liabilities:
      		                     
        accounts payable
      		4,613,000 3,233,000 6,397,000 8,378,000 7,707,000 12,932,000 8,987,000 5,828,000 4,709,000 6,851,000 3,194,000 4,154,000 5,329,000 6,826,000 1,592,000 2,410,000 2,524,000 1,329,000 1,249,000 1,350,000 969,000 
        accrued expenses and other current liabilities
      		3,442,000 6,407,000 8,381,000 8,435,000 10,684,000 6,662,000 15,893,000 16,046,000 17,379,000 13,543,000 10,191,000 7,486,000 10,834,000 11,657,000 10,392,000 6,361,000 4,860,000 2,743,000 3,838,000 3,116,000  
        operating lease liabilities, current
      		1,239,000 1,461,000 787,000 755,000 1,426,000 2,079,000 2,692,000 3,289,000 3,166,000 2,466,000 2,825,000 2,717,000 2,611,000 618,000 605,000       
        total current liabilities
      		9,294,000 11,101,000 15,565,000 17,568,000 19,817,000 21,673,000 27,572,000 25,163,000 25,254,000 22,860,000 16,210,000 14,357,000 18,774,000 19,101,000 12,589,000 9,362,000 7,962,000 4,637,000 5,641,000 4,942,000 3,919,000 
        operating lease liabilities, non-current
      		 128,000 6,089,000 6,299,000 6,501,000 6,692,000 6,875,000 7,053,000 7,926,000 7,830,000 9,265,000 10,012,000 10,735,000 1,667,000 1,826,000       
        warrant liability, non-current
      		18,372,000 17,791,000 17,914,000 21,786,000                  
        total liabilities
      		27,666,000 29,020,000 39,568,000 45,653,000 26,318,000 28,365,000 34,447,000 32,216,000 33,180,000 30,690,000 25,475,000 24,369,000 29,509,000 20,768,000 14,415,000 11,346,000 10,099,000 6,922,000 8,072,000 7,517,000 3,919,000 
        commitments and contingencies
      		                     
        stockholders' equity:
      		                     
        preferred stock, 0.0001 par value...
      		                     
        common stock, 0.0001 par value...
      		7,000 7,000 6,000 6,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 3,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 1,000 
        additional paid-in capital
      		480,175,000 478,593,000 469,273,000 464,757,000 445,246,000 438,820,000 433,917,000 429,106,000 423,196,000 418,058,000 413,549,000 409,813,000 243,747,000 240,107,000 236,901,000 233,770,000 230,893,000 228,532,000 226,359,000 224,438,000 14,262,000 
        accumulated deficit
      		-461,463,000 -449,048,000 -453,660,000 -437,253,000 -416,513,000 -387,251,000 -357,949,000 -325,162,000 -287,886,000 -248,825,000 -213,941,000 -185,512,000 -160,621,000 -131,570,000 -106,256,000 -83,366,000 -66,108,000 -49,742,000 -35,032,000 -22,426,000 -14,027,000 
        total stockholders' equity
      		18,719,000 29,552,000 15,619,000 27,510,000 28,737,000 51,573,000 75,972,000 103,948,000 135,314,000 169,237,000 199,612,000 224,305,000 83,129,000 108,539,000 130,635,000 150,390,000 164,765,000 178,783,000 191,331,000 202,016,000 221,000 
        total liabilities and stockholders' equity
      		46,385,000 58,572,000 55,187,000 73,163,000 55,055,000 79,938,000 110,419,000 136,164,000 168,494,000 199,927,000 225,087,000 248,674,000 112,638,000 129,307,000 145,050,000 161,736,000 174,864,000  199,403,000 209,533,000 59,875,000 
        restricted cash
      		 369,000 369,000 369,000 369,000 369,000 369,000 369,000 369,000 370,000 369,000 351,000 351,000 351,000 351,000 351,000 351,000 351,000 216,000 216,000 216,000 
        other non-current assets
      		   4,000 617,000                 
        operating lease right-of-use assets
      		  5,178,000 5,296,000 6,086,000 6,852,000 7,595,000 8,315,000 9,013,000 9,714,000 11,810,000 12,502,000 13,175,000 2,151,000 2,296,000 2,440,000 2,582,000 2,722,000    
        other assets
      		     619,000 4,629,000 6,747,000 6,740,000 5,503,000 4,829,000 3,906,000 3,889,000 3,145,000 483,000 1,624,000 1,599,000 1,230,000    
        accumulated other comprehensive income
      		              -13,000 -17,000 -23,000  2,000 2,000  
        short-term investments
      		             1,150,000 1,147,000 1,152,000 8,591,000 27,780,000 32,431,000 32,535,000 26,586,000 
        long-term investments
      		              10,000 186,000 415,000 1,876,000 2,238,000 4,256,000 11,843,000 
        accumulated other comprehensive loss
      		             -1,000    -10,000   -15,000 
        short-term operating lease liabilities
      		               591,000 578,000 565,000 554,000   
        long-term operating lease liabilities
      		               1,984,000 2,137,000 2,285,000 2,431,000   
        liabilities, convertible preferred stock and stockholders' equity
      		                     
        loan payable
      		                    36,000 
        series a convertible preferred stock, 0.0001 par value...
      		                    55,735,000 
        total liabilities, convertible preferred stock, and stockholders' equity
      		                 185,705,000    
        prepaid and other long-term assets
      		                  23,000   
        right-of-use assets
      		                  2,860,000   
        stockholders' equity
      		                     
        prepaid and other long term assets
      		                     
        right-of-use asset
      		                   3,045,000 129,000 
        short-term operating lease liability
      		                   476,000  
        long-term operating lease liability
      		                   2,575,000  
        accrued liabilities
      		                    2,777,000 
        lease liability
      		                    137,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                             
          operating activities
        		                     
          net loss
        		-12,415,000 4,612,000 -16,407,000 -20,740,000 -29,262,000 -29,302,000 -32,787,000 -37,276,000 -39,061,000 -34,884,000 -28,429,000 -24,891,000 -29,051,000 -25,314,000 -22,890,000 -17,258,000 -16,366,000 -14,710,000 -12,606,000 -8,399,000 -5,852,000 
          adjustments to reconcile net loss to net cash from operating activities:
        		                     
          depreciation expense
        		46,000 47,000 427,000 467,000 468,000 469,000 436,000 423,000 420,000 420,000 419,000 383,000 293,000 181,000 174,000 170,000 166,000     
          non-cash operating lease expense
        		 173,000 117,000 791,000 766,000 742,000 720,000 377,000 999,000 710,000 691,000 673,000 612,000 145,000 144,000 142,000 140,000 138,000 185,000   
          stock-based compensation expense
        		1,582,000 1,838,000 1,940,000 2,573,000 3,169,000 4,490,000 4,742,000 4,840,000 5,022,000 3,864,000 3,598,000 3,436,000 3,233,000 2,716,000 2,731,000 2,559,000 2,330,000 1,931,000 1,921,000 1,463,000 919,000 
          change in fair value of warrant liability
        		581,000 -15,758,000 -3,872,000                   
          gain on sale of property and equipment
        		-510,000                     
          changes in operating assets and liabilities:
        		                     
          prepaid expenses and other current assets
        		982,000 560,000 5,641,000 382,000 1,232,000 -4,407,000 -2,644,000 -354,000 -333,000 1,122,000 -386,000 -603,000 2,345,000 633,000 -898,000 -2,288,000 828,000 -1,347,000 251,000   
          other assets
        		  4,000 613,000 2,000 4,010,000 2,118,000 -8,000 -1,236,000 -674,000 -923,000 -17,000 -744,000 -2,662,000 1,141,000 -25,000 -369,000 -1,207,000 -23,000 0 12,000 
          accounts payable
        		1,380,000 -3,169,000 -1,828,000 517,000 -5,220,000 4,020,000 3,126,000 1,118,000 -2,176,000 3,661,000 -936,000 -828,000 665,000 2,973,000 -1,094,000 -114,000 1,195,000 221,000 182,000 196,000 41,000 
          accrued expenses and other current liabilities
        		-2,965,000 -1,963,000 400,000 -2,714,000 4,022,000 -9,231,000 -153,000 -1,333,000 3,836,000 3,352,000 2,705,000 -3,348,000 -823,000 1,265,000 4,031,000 1,501,000 2,117,000 -1,095,000 946,000   
          operating lease liabilities
        		-350,000 -282,000 -177,000 -874,000 -844,000 -795,000 -775,000 -430,000 499,000 -408,000 -638,000 -617,000 -575,000 -146,000 -144,000 -140,000 -135,000     
          net cash from operating activities
        		-11,669,000 -13,942,000 -11,550,000 -19,212,000 -25,667,000 -30,004,000 -25,217,000 -32,643,000 -32,030,000 -22,837,000 -23,899,000 -25,812,000 -24,044,000 -20,201,000 -16,795,000 -15,427,000 -9,994,000 -15,899,000 -8,988,000 -6,476,000 -4,075,000 
          capital expenditures
        		0 0 0 0  -143,000 -153,000 -58,000 -1,000 -8,000 -63,000 -764,000 -2,531,000 -712,000 50,000 -273,000  -293,000 -2,040,000 -771,000 -67,000 
          free cash flows
        		-11,669,000 -13,942,000 -11,550,000 -19,212,000  -30,147,000 -25,370,000 -32,701,000 -32,031,000 -22,845,000 -23,962,000 -26,576,000 -26,575,000 -20,913,000 -16,745,000 -15,700,000  -16,192,000 -11,028,000 -7,247,000 -4,142,000 
          investing activities
        		                     
          proceeds from sale of property and equipment
        		550,000                     
          net cash from investing activities
        		550,000     -82,000 -186,000 -59,000 -35,000 -8,000 -39,000 -417,000 -1,756,000 -701,000 225,000 7,375,000 20,442,000 4,550,000 -75,000 680,000 -38,510,000 
          financing activities
        		                     
          proceeds from issuances of common stock under at the market equity offering program, net of offering costs
        		                     
          payments of financing costs
        		  -628,000 -120,000 -5,000                 
          net cash from financing activities
        		 23,112,000 1,968,000 39,572,000 3,252,000 413,000 69,000 1,070,000 116,000 622,000 138,000 162,837,000 201,000 490,000 400,000 318,000 31,000 246,000 0 152,942,000 -3,000 
          net decrease in cash, cash equivalents, and restricted cash
        		-11,119,000  -9,582,000 20,360,000 -22,415,000    -31,949,000            -42,588,000 
          cash, cash equivalents, and restricted cash at the beginning of the period
        		56,181,000 0 0 0 58,648,000 0 0 0 177,236,000 0 0 0 112,250,000 0 0 0 146,087,000 0 0 0 61,695,000 
          cash, cash equivalents, and restricted cash at the end of the period
        		45,062,000 9,170,000 -9,582,000 20,360,000 36,233,000 -29,673,000 -25,334,000 -31,632,000 145,287,000 -22,223,000 -23,800,000 136,608,000 86,651,000 -20,412,000 -16,170,000 -7,734,000 156,566,000 -11,103,000 -9,063,000 147,146,000 19,107,000 
          non-cash financing and investing activities:
        		                     
          financing costs included in accounts payable and accrued liabilities
        		  -608,000                   
          reconciliation of cash and cash equivalents, and restricted cash:
        		                     
          cash and cash equivalents
        		44,693,000 9,170,000 -9,582,000 20,360,000 35,864,000 -29,673,000 -25,334,000 -31,632,000 144,918,000 -22,224,000 -23,818,000 136,608,000 86,300,000 -20,412,000 -16,170,000 -7,734,000 156,215,000 -11,238,000 -9,063,000 147,146,000 18,891,000 
          restricted cash
        		369,000 0 0 0 369,000 0 0 0 369,000 1,000 18,000 0 351,000 0 0 0 351,000 135,000 0 0 216,000 
          total cash and cash equivalents, and restricted cash
        		45,062,000  -9,582,000 20,360,000 36,233,000  -25,334,000 -31,632,000 145,287,000             
          cash flows from operating activities
        		                     
          adjustments to reconcile net loss to net cash from operating activities
        		                     
          net amortization of premiums and accretion of discounts on investments
        		         0 0 0 1,000 8,000 10,000 26,000 100,000 155,000 157,000   
          impairment of long-lived assets
        		                     
          other non-current assets
        		                     
          cash flows from investing activities
        		                     
          purchase of property and equipment
        		     -82,000 -186,000 -59,000 -35,000 -8,000 -39,000 -417,000 -2,906,000 -712,000 50,000 -273,000 -95,000 -293,000 -2,040,000 -771,000 -67,000 
          maturities of investments
        		         0 0 0 1,150,000 11,000 175,000 7,648,000 20,537,000 4,843,000    
          cash flows from financing activities
        		                     
          proceeds from issuance of common stock under at the market equity offering program, net of offering costs
        		                     
          proceeds from issuance of common stock, common warrants and pre-funded warrants, net of offering costs
        		                     
          proceeds from stock options exercised and purchases under the employee stock purchase plan
        		                     
          net increase in cash, cash equivalents, and restricted cash
        		     -29,673,000 -25,334,000    -23,800,000 136,608,000 -25,599,000 -20,412,000 -16,170,000 -7,734,000 10,479,000 -11,103,000 -9,063,000   
          acquisition of operating lease right-of-use assets
        		         -5,668,000 0 0 11,639,000         
          acquisition of property and equipment in accounts payable and accrued liabilities
        		     -61,000 33,000 1,000 34,000  -24,000 -347,000 375,000         
          remeasurement of operating lease right-of-use assets and lease liability
        		                     
          reconciliation of cash, cash equivalents and restricted cash:
        		                     
          total cash, cash equivalents and restricted cash
        		              -16,170,000       
          impairment of property and equipment
        		                     
          proceeds from issuances of common stock under at the market equity offering program
        		  0                   
          proceeds from issuance of common stock, common warrants and pre-funded warrants from public offerings
        		                     
          proceeds from stock option exercise and purchases under the employee stock purchase plan
        		  0    69,000    138,000    400,000       
          proceeds from issuance of common stock, common warrants and pre-funded warrants from public offering
        		                     
          proceeds from issuances of common stock under atm program
        		    3,257,000                 
          proceeds from stock option exercise
        		        116,000    201,000    31,000  0   
          financing costs included in accounts payable
        		    5,000                 
          proceeds from issuance of common stock, net of offering costs
        		                     
          proceeds from issuance of common stock from public offering, net of offering costs
        		          0           
          purchase of investments
        		                 0    
          proceeds from issuance of common stock, net of issuance costs
        		                     
          proceeds from issuance of common stock from initial public offering, net of issuance costs
        		                     
          proceeds from exercise of stock options and purchases under the employee stock purchase plan
        		                     
          payment from paycheck protection program loan
        		                     
          net increase (net decrease) in cash, cash equivalents, and restricted cash
        		                     
          acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities
        		                     
          reconciliation of cash, cash equivalents, and restricted cash:
        		                     
          total cash, cash equivalents, and restricted cash
        		                     
          reconciliation of cash and cash equivalents and restricted cash:
        		                     
          total cash and cash equivalents and restricted cash
        		          -23,800,000 136,608,000 86,651,000    156,566,000     
          proceeds from issuance of series a convertible preferred stock, net of issuance costs
        		                     
          proceeds (payment) from paycheck protection program loan
        		                 0    
          unpaid deferred offering costs
        		                    1,226,000 
          net proceeds from issuance of common stock from initial public offering
        		                  0   
          series a financing costs incurred
        		                  0 0 -3,000 
          payment of paycheck protection program loan
        		                     
          conversion of series a convertible preferred stock into common stock
        		                     
          acquisition of property and equipment included in accounts payable and accrued liabilities
        		                     
          depreciation
        		                  65,000 23,000 11,000 
          lease liabilities
        		                  -66,000 -302,000 -86,000 
          proceeds from issuance of common stock from seed series
        		                     
          conversion of convertible preferred stock into common stock
        		                  0   
          acquisition of right of use asset
        		                  0   
          acquisition of fixed assets in accounts payable and accrued liabilities
        		                  -507,000   
          change in unrealized gain on investments
        		                  0   
          total cash and cash equivalents and restricted cash - end of period
        		                  -9,063,000 147,146,000 19,107,000 
          purchase of short-term and long-term investments
        		                   -49,000 -38,443,000 
          maturities of short-term and long-term investments
        		                     
          proceeds from issuance of common stock from series seed
        		                     
          proceeds from paycheck protection program loan
        		                     
          non-cash lease expense
        		                    81,000 
          prepaid expenses & other current assets
        		                    -292,000 
          accrued liabilities
        		                    1,091,000 
          proceeds from issuance of common stock
        		                     
          acquisition of fixed assets
        		                    29,000 
          change in unrealized gain/loss on investments
        		                    -15,000